Ad is loading...
BEAM
Price
$23.58
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
102 days until earnings call
VTGN
Price
$2.53
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

BEAM vs VTGN

Header iconBEAM vs VTGN Comparison
Open Charts BEAM vs VTGNBanner chart's image
Beam Therapeutics
Price$23.58
Change-$0.00 (-0.00%)
Volume$1.01M
CapitalizationN/A
VistaGen Therapeutics
Price$2.53
Change-$0.00 (-0.00%)
Volume$195.03K
CapitalizationN/A
BEAM vs VTGN Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. VTGN commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and VTGN is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (BEAM: $23.58 vs. VTGN: $2.53)
Brand notoriety: BEAM and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 94% vs. VTGN: 92%
Market capitalization -- BEAM: $2.07B vs. VTGN: $70.44M
BEAM [@Biotechnology] is valued at $2.07B. VTGN’s [@Biotechnology] market capitalization is $70.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -10.38% price change this week, while VTGN (@Biotechnology) price change was -7.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.07B) has a higher market cap than VTGN($71.8M). BEAM YTD gains are higher at: -13.373 vs. VTGN (-50.778). VTGN has higher annual earnings (EBITDA): -45M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. VTGN (97.6M). VTGN has less debt than BEAM: VTGN (1.79M) vs BEAM (162M). BEAM has higher revenues than VTGN: BEAM (350M) vs VTGN (876K).
BEAMVTGNBEAM / VTGN
Capitalization2.07B71.8M2,889%
EBITDA-160.83M-45M357%
Gain YTD-13.373-50.77826%
P/E RatioN/AN/A-
Revenue350M876K39,954%
Total Cash926M97.6M949%
Total Debt162M1.79M9,030%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGEN2.860.19
+7.12%
Agenus
VNT38.320.96
+2.56%
Vontier Corp
STC73.791.44
+1.99%
Stewart Information Services Corp
SYK390.144.46
+1.16%
Stryker Corp
CIX27.81-0.17
-0.61%
Comp X International

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.07%
NTLA - VTGN
46%
Loosely correlated
+5.18%
ALT - VTGN
45%
Loosely correlated
+4.41%
KYMR - VTGN
43%
Loosely correlated
-1.23%
IOVA - VTGN
43%
Loosely correlated
+1.23%
BEAM - VTGN
43%
Loosely correlated
-3.72%
More